Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: A Cross-sectional study of 1,032 medical inpatients

Journal of General Internal Medicine

Volumn 19, Issue 8, 2004, Pages 849-855

  Labarère, José ^a   Bosson, Jean Luc ^a   Bergmann, Jean François ^b   Thilly, Nathalie ^c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c CENTRE HOSPITALIER   (France)

Author keywords

Heparin; Low molecular weight; Practice guidelines; Pulmonary embolism; Venous thrombosis

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPARINIZATION; HOSPITAL PATIENT; HUMAN; INFORMATION DISSEMINATION; MALE; MEDICAL PRACTICE; PRACTICE GUIDELINE; PROPHYLAXIS; TEACHING HOSPITAL; VENOUS THROMBOEMBOLISM;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; FRANCE; GUIDELINE ADHERENCE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 4143049241     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.30603.x     Document Type: Article

References (31)

1. Anderson FA Jr., Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152:1660-4.
2. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-75S.
3. Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost. 2000;83:14-9.
4. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793-800.
5. Bosson JL, Labarere J, Sevestre MA, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities. A multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med. 2003;163:2613-8.
6. Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward. J Gen Intern Med. 2002;17:788-91.
7. Bergmann J, Mahe I. Prevention of venous thromboembolism in medical patients (in French). Ann Med Interne. 2000;151:207-14.
8. Fagot JP, Flahault A, Kanfer A, et al. Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin (in French). Presse Med. 2000;29:4-10.
9. Thilly N, Pierson H, Collard C, Lecompte T, Dufay E. Prophylaxis of venous thromboembolism in medical patients: from medical decision tools to the use of low molecular weight heparin (in French). Therapie. 1998;53:579-86.
10. Institute of Medicine. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990.
11. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-65.
12. Woolf SH. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med. 1993;153:2646-55.
13. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001;358:9-15.
14. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-80.
15. Levine M, Hirsh J, Gent M, et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet. 1994;343:886-9.
16. Fagot JP, Flahault A, Fodil M, et al. Prophylactic prescription of low-molecular-weight heparin in the non-surgical setting: impact of recommendations (in French). Presse Med. 2001;30:203-8.
17. Siegel S, Castellan J. Nonparametric Statistics for the Behavioral Sciences. 2nd ed. New York, NY: McGraw Hill; 1988.
18. Fahey TP, Peters TJ. What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ. 1996; 313:93-6.
19. Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ. 1998;316:509-13.
20. Lomas J, Anderson G, Enkin M, Vayda E, Roberts R, MacKinnon B. The role of evidence in the consensus process. Results from a Canadian consensus exercise. JAMA. 1988;259:3001-5.
21. Bergmann JF, Caulin C. Heparin prophylaxis in bedridden patients. Lancet. 1996;348:205-6.
22. Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet. 1996;347: 1357-61.
23. Institute of Medicine. Guidelines for Clinical Practice: From Development to Use. Washington, DC: National Academy Press; 1992.
24. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual. RAND Corporation; 2001.
25. Bernstein SJ, Lazaro P, Fitch K, Aguilar MD, Kahan JP. Effect of specialty and nationality on panel judgments of the appropriateness of coronary revascularization: a pilot study. Med Care. 2001;39:513-20.
26. Leape LL, Hilborne LH, Schwartz JS, et al. The appropriateness of coronary artery bypass graft surgery in academic medical centers. Working Group of the Appropriateness Project of the Academic Medical Center Consortium. Ann Intern Med. 1996;125:8-18.
27. Pazart LH, Mattillon Y, Massol J. Problems with guidelines. Clinical practice must be taken into account when guidelines are drawn up. BMJ. 1997;314:518-9.
28. Woodhead M. Community-acquired pneumonia guidelines: much guidance, but not much evidence. Eur Respir J. 2002;20:1-3.
29. Fielding JE, Lancry PJ. Lessons from France - 'vive la difference.' The French health care system and US health system reform. JAMA. 1993;270:748-56.
30. Wietlisbach V, Vader JP, Porchet F, Costanza MC, Burnand B. Statistical approaches in the development of clinical practice guidelines from expert panels: the case of laminectomy in sciatica patients. Med Care. 1999;37:785-97.
31. Lederle FA. Heparin prophylaxis for medical patients? Ann Intern Med. 1998;128:768-70.